Rise in the Arthroscopic Device Market due to Physician Demand for Premium-Priced Resorbable Technologies
According to a new report entitled, US Markets for Arthroscopic Devices 2006, this market was valued at over $950 million in 2005 and will surpass $1.3 billion by 2010.
Waltham, MA (PRWEB) September 13, 2006
Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that the US arthroscopic device market will continue to rise in value throughout the next five years, due in large part to arthroscopic procedure volume growth and customer demand for newer, more expensive technologies. This market includes anterior/posterior cruciate ligament (ACL/PCL) reconstruction, powered shaver systems, shoulder fixation, radiofrequency probes, fluid management, meniscal repair, arthroscopes, cartilage repair, hand instruments and rotator cuff repair devices. According to a new report entitled, US Markets for Arthroscopic Devices 2006, this market was valued at over $950 million in 2005 and will surpass $1.3 billion by 2010.
The rise in the arthroscopic device market can be largely attributed to escalating physician demand for premium-priced resorbable technologies. The popularity of resorbable devices continues to increase due to the clinical advantages these devices offer over their metal counterparts. Traditional metal devices are prone to complications such as dislodgement and migration within the body, and require that the device be removed if additional surgical revisions are necessary. As a result, a number of market segments, including ACL/PCL reconstruction, shoulder fixation, and meniscal repair, are experiencing a strong shift toward resorbable product lines. Because resorbable implants carry a higher average selling price, the cannibalization of nonresorbable metal implants will increase the market value of these segments.
MRG’s US Markets for Arthroscopic Devices 2006 report covers all key industry competitors, including Smith & Nephew Endoscopy (SNN), Conmed Linvatec (CNMD), Arthrex, Depuy Mitek (JNJ), Stryker Endoscopy (SYK), Arthocare (ARTC), Genzyme Biosurgery (GENZ), Davol (BCR), Karl Storz Endoscopy and Arthrotek. The report is part of MRG’s Global Markets for Endoscopy series, which also includes analysis on the European and Japanese markets and covers all major areas of the endoscopy market including: arthroscopy, ENT/bronchscopy, gastro-intestinal endoscopy and laparoscopy.
About Resorbable Devices
Resorbable devices are comprised solely of biological materials such as hydroxyapatite (HA) and tricalcium phosphate (TCP) that are naturally absorbed by the body over the course of healing. Within a period of 12 to 24 months, these devices are completely absorbed into the body.
About Millennium Research Group
Millennium Research Group (www. MRG. net), a Decision Resources, Inc. company (www. DecisionResources. com), is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101
###
